Xtal Concepts

Xtal Concepts

Munich, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Xtal Concepts is a privately-held instrumentation company serving the structural biology and biopharmaceutical research markets. Its core technology is the SpectroLight 600, a high-throughput dynamic light scattering (DLS) instrument that dramatically accelerates sample quality assessment and optimization for techniques like crystallography, cryo-EM, and SAXS. By enabling rapid analysis of monodispersity, aggregation, and size with minimal sample volume, the company addresses a key bottleneck in the drug discovery pipeline. Xtal Concepts appears to be in a revenue-generating stage, actively selling its instruments and showcasing them at major scientific conferences.

Drug Delivery

Technology Platform

High-throughput dynamic light scattering (DLS) instrumentation, specifically the SpectroLight 600, for characterizing nano- and microparticles in liquids. Enables rapid, low-volume sample analysis for optimizing conditions in structural biology techniques like crystallography, cryo-EM, and SAXS.

Opportunities

Growth is driven by the expanding biologics market and the increasing reliance on structural biology techniques like cryo-EM, which require high-quality, well-characterized samples.
The company's high-throughput, low-volume solution addresses a critical bottleneck, offering significant time and cost savings for research and development pipelines.

Risk Factors

Faces competition from large, established instrumentation companies in the biophysical analysis space.
Market is niche, tied to structural biology and protein research funding cycles.
As a small private company, may have limited resources for global sales expansion and R&D compared to larger competitors.

Competitive Landscape

Operates in the biophysical characterization instrument market, competing directly with the DLS product lines of major players like Malvern Panalytical (Zetasizer) and Wyatt Technology (DynaPro). Differentiation is achieved through ultra-high-throughput design using microplates, minimal sample consumption, and a focused workflow for structural biology sample preparation.